Six Reasons Drug Prices Are So High in the U.S.news2024-01-17T18:53:05+00:00January 17th, 2024|The New York Times|
F.D.A. to Issue First Approval for Mass Drug Imports to States from Canadanews2024-01-05T18:06:59+00:00January 5th, 2024|The New York Times|
Biden Administration Unveils First Drugs for Medicare Price Negotiationsnews2023-08-29T22:50:39+00:00August 29th, 2023|The New York Times|
Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiationsnews2023-07-23T07:00:18+00:00July 23rd, 2023|The New York Times|
FDA’s Drug Industry Fees Fuel Concerns Over Influencenews2022-09-15T09:00:26+00:00September 15th, 2022|The New York Times|
Medicare Recipients Could Find Drug Cost Relief in Health Billnews2022-08-10T07:00:11+00:00August 10th, 2022|The New York Times|
Democrats Offer Plan to Cut Drug Costs, Seeking Climate and Tax Dealnews2022-07-06T19:17:56+00:00July 6th, 2022|The New York Times|
Boss Trump, ‘the Sorest Loser of All Time’news2022-04-24T15:30:06+00:00April 24th, 2022|The New York Times|
Democrats’ Campaign to Control Drug Prices Nears Collapsenews2021-10-21T21:49:36+00:00October 21st, 2021|The New York Times|
With Biden’s Agenda in the Balance, Lobbying Kicks Into High Gearnews2021-10-05T00:38:57+00:00October 5th, 2021|The New York Times|
